Clinical Trials Related to Emtricitabine

Related studies linked through entity extraction aliases.

A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Pharmacokinetics of Antiretroviral Drugs in Lactating Women and Breastmilk Fed Infants Under 6 Months of Age in Botswana

Status: COMPLETED
Phase: N/A

Evaluation of Drug Interaction Between HS-10234 and Emtriccitabine

Status: COMPLETED
Phase: PHASE1

Role of Exogenous and Endogenous Sex Hormones on Tenofovir and Emtricitabine Disposition in Female Genital Tract

Status: COMPLETED
Phase: N/A

PK and PD Study of Oral F/TAF for HIV Prevention

Status: COMPLETED
Phase: PHASE1

Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection

Status: COMPLETED
Phase: PHASE1/PHASE2

Emtricitabine for Prevention of Vertical Transmission of HBV in Chinese Pregnant HBsAg Positive Patients

Status: UNKNOWN
Phase: PHASE4

Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B Patients

Status: UNKNOWN
Phase: PHASE4

Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients

Status: UNKNOWN
Phase: PHASE4

Emtricitabine for Naive Chinese Chronic Hepatitis B Patients

Status: UNKNOWN
Phase: PHASE4

Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)

Status: TERMINATED
Phase: PHASE2

Study to Evaluate a HIV Drug for the Treatment of HIV Infection

Status: COMPLETED
Phase: PHASE2

A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment

Status: COMPLETED
Phase: PHASE3

Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women

Status: COMPLETED
Phase: PHASE2

Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen

Status: COMPLETED
Phase: PHASE2

The Safety, Pharmacokinetic Profile and Efficacy of Raltegravir in HIV-infected Patients at Least 60 Years of Age

Status: COMPLETED
Phase: PHASE4

Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in Healthy Women

Status: COMPLETED
Phase: PHASE4

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years

Status: COMPLETED
Phase: PHASE2

Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine

Status: COMPLETED
Phase: PHASE2

An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects

Status: COMPLETED
Phase: PHASE2